NEIL C JOSEPHSON, MD
Osteopathic Medicine at Terry Ave, Seattle, WA

License number
Washington MD00031755
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
921 Terry Ave, Seattle, WA 98104
Phone
(206) 292-6570

Personal information

See more information about NEIL C JOSEPHSON at radaris.com
Name
Address
Phone
Neil Josephson
3118 Lakewood Ave S, Seattle, WA 98144
Neil Josephson
Seattle, WA
(206) 522-7065
Neil Josephson
6819 Phinney Ave N, Seattle, WA 98103
Neil Josephson
515 83Rd St, Seattle, WA 98115
Neil Josephson
515 83Rd St, Seattle, WA 98115

Professional information

Neil C Josephson Photo 1

Dr. Neil C Josephson, Seattle WA - MD (Doctor of Medicine)

Specialties:
Hematology, Medical Oncology, Oncology
Address:
Hemophilia Care Program
921 Terry Ave, Seattle 98104
(206) 292-6570 (Phone)
Certifications:
Hematology, 2008, Internal Medicine, 1991, Medical Oncology, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Hemophilia Care Program
921 Terry Ave, Seattle 98104
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1988
Yale University
Graduated: 1945
Northwestern Memorial Hospital
University Of Washington


Neil C Josephson Photo 2

Neil C Josephson, Seattle WA

Specialties:
Hematologist
Address:
921 Terry Ave, Seattle, WA 98104
Education:
Columbia University, College of Physicians and Surgeons - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)


Neil C Josephson Photo 3

Neil C Josephson, Seattle WA

Specialties:
Hematology, Hematology & Oncology, Medical Oncology
Work:
Puget Sound Blood Ctr
921 Terry Ave, Seattle, WA 98104
Education:
Columbia University (1988)


Neil Josephson Photo 4

Suppression Of Immune Response To Factor Viii In Hemophilia A Patients

US Patent:
2010023, Sep 16, 2010
Filed:
Mar 10, 2010
Appl. No.:
12/721361
Inventors:
Neil Cary Josephson - Seattle WA, US
International Classification:
A61K 38/20, A61K 39/00, A61K 38/37, A61P 37/06, A61P 7/04
US Classification:
424 852, 4241841, 514 12
Abstract:
This invention relates to methods and compositions for suppressing an immune response to Factor VIII in subjects suffering from hemophilia A and having preformed inhibitor antibodies against Factor VIII, and compositions and methods that advantageously render subjects amenable to standard treatments for hemophilia A, including Factor VIII replacement therapy.